MedPath

The Chewing study: The effects of chewing duration on blood glucose levels

Conditions
gezonde voedselkeuze
healthy food choice
Registration Number
NL-OMON50095
Lead Sponsor
Wageningen UR; Stichting DLO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
26
Inclusion Criteria

* Apparently healthy men and women (based on questionnaire, self-reported)
* Aged between 18 * 55 yrs
* BMI between 18.5 and 30

Exclusion Criteria

Participants will be excluded if:
* Employed by the FHCR group of Wageningen Food & Biobased Research.
* BMI > 30.0 en < 18.5
* Diagnosed with Diabetes mellitus type 1 or 2
* Under treatment for neurological or psychiatric complaints, including eating
disorders
* History of gastro-intestinal surgery or having (serious) gastro-intestinal
complaints
* Use of medication/supplements that may influence the study results, such as
medicines known to interfere with glucose homeostasis. This will be judged by
our medical doctor
* Following a diet or gained/lost >=5kg weight in the previous month.
* Coeliac disease or gluten intolerance
* Skin allergy, eczema or known sensitivity for plasters
* use of drugs
* Current smokers
* Using > 14 glasses of alcohol/week
* Having food allergies
* Participation in another clinical trial at the same time
* Gastric emptying disorder.
* Problems with chewing and/or swallowing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primaire study parameter is bloodglucose levels during the 3-hours following a<br /><br>test lunch consumed following a long/short chewing protocol. Blood glucose<br /><br>parameters are: time-to-peak, maximum value and area under the curve.<br /><br></p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are salivary amylase and particle sizes of the food<br /><br>boli at the moment of swallowing.</p><br>
© Copyright 2025. All Rights Reserved by MedPath